

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.50536844 |
| 2 | protein carboxylation (GO:0018214) | 4.50536844 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.03274542 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.03274542 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 3.79553324 |
| 6 | cellular ketone body metabolic process (GO:0046950) | 3.62210723 |
| 7 | response to pheromone (GO:0019236) | 3.62189657 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.60322768 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60322768 |
| 10 | tryptophan metabolic process (GO:0006568) | 3.58398462 |
| 11 | tyrosine metabolic process (GO:0006570) | 3.55045960 |
| 12 | tryptophan catabolic process (GO:0006569) | 3.51373384 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.51373384 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.51373384 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 3.42196524 |
| 16 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.31483683 |
| 17 | complement activation, alternative pathway (GO:0006957) | 3.27160197 |
| 18 | keratinocyte development (GO:0003334) | 3.27029174 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26347733 |
| 20 | ketone body metabolic process (GO:1902224) | 3.24352949 |
| 21 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.22520580 |
| 22 | urea metabolic process (GO:0019627) | 3.20173468 |
| 23 | urea cycle (GO:0000050) | 3.20173468 |
| 24 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.19296987 |
| 25 | limb bud formation (GO:0060174) | 3.17984588 |
| 26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.17694132 |
| 27 | homocysteine metabolic process (GO:0050667) | 3.15612476 |
| 28 | reverse cholesterol transport (GO:0043691) | 3.13520626 |
| 29 | prenylation (GO:0097354) | 3.11039696 |
| 30 | protein prenylation (GO:0018342) | 3.11039696 |
| 31 | negative regulation of glycogen metabolic process (GO:0070874) | 3.08798287 |
| 32 | regulation of keratinocyte proliferation (GO:0010837) | 3.08228527 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.06114872 |
| 34 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.04917546 |
| 35 | positive regulation of protein autophosphorylation (GO:0031954) | 3.03766121 |
| 36 | regulation of mesoderm development (GO:2000380) | 3.03140318 |
| 37 | artery development (GO:0060840) | 3.02774762 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 3.02114315 |
| 39 | bile acid biosynthetic process (GO:0006699) | 3.01953661 |
| 40 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.01034289 |
| 41 | hemidesmosome assembly (GO:0031581) | 2.97026136 |
| 42 | phospholipid efflux (GO:0033700) | 2.96792757 |
| 43 | anterior/posterior axis specification, embryo (GO:0008595) | 2.95601464 |
| 44 | embryonic foregut morphogenesis (GO:0048617) | 2.94706081 |
| 45 | organ formation (GO:0048645) | 2.94627497 |
| 46 | fibrinolysis (GO:0042730) | 2.94158160 |
| 47 | regulation of fibrinolysis (GO:0051917) | 2.94026913 |
| 48 | regulation of protein activation cascade (GO:2000257) | 2.93884612 |
| 49 | desmosome organization (GO:0002934) | 2.93608251 |
| 50 | dorsal/ventral axis specification (GO:0009950) | 2.91999641 |
| 51 | alanine transport (GO:0032328) | 2.91639988 |
| 52 | cholesterol efflux (GO:0033344) | 2.90928871 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89742024 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 2.89742024 |
| 55 | macromolecular complex remodeling (GO:0034367) | 2.89742024 |
| 56 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.89253999 |
| 57 | negative regulation of axon guidance (GO:1902668) | 2.88225013 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 2.87611573 |
| 59 | smooth muscle tissue development (GO:0048745) | 2.87050192 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 2.87004639 |
| 61 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.86503353 |
| 62 | lymphangiogenesis (GO:0001946) | 2.81612924 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 2.80389060 |
| 64 | neural crest cell development (GO:0014032) | 2.78823330 |
| 65 | negative regulation of lipase activity (GO:0060192) | 2.77989782 |
| 66 | triglyceride homeostasis (GO:0070328) | 2.77848637 |
| 67 | acylglycerol homeostasis (GO:0055090) | 2.77848637 |
| 68 | otic vesicle formation (GO:0030916) | 2.76919424 |
| 69 | negative chemotaxis (GO:0050919) | 2.75827566 |
| 70 | glyoxylate metabolic process (GO:0046487) | 2.75184220 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.74906605 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.74902268 |
| 73 | regulation of complement activation (GO:0030449) | 2.74803932 |
| 74 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.73460566 |
| 75 | positive regulation of glycolytic process (GO:0045821) | 2.73139477 |
| 76 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.73135462 |
| 77 | chondrocyte proliferation (GO:0035988) | 2.71296065 |
| 78 | lateral sprouting from an epithelium (GO:0060601) | 2.70792703 |
| 79 | alkaloid metabolic process (GO:0009820) | 2.70768108 |
| 80 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.65957488 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 2.64231974 |
| 82 | proline transport (GO:0015824) | 2.63809504 |
| 83 | bile acid metabolic process (GO:0008206) | 2.63783940 |
| 84 | plasma lipoprotein particle clearance (GO:0034381) | 2.63208714 |
| 85 | pericardium development (GO:0060039) | 2.62715857 |
| 86 | ER overload response (GO:0006983) | 2.60571308 |
| 87 | amine catabolic process (GO:0009310) | 2.60004552 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 2.60004552 |
| 89 | phospholipid homeostasis (GO:0055091) | 2.57785839 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 2.57517919 |
| 91 | regulation of sarcomere organization (GO:0060297) | 2.57226947 |
| 92 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.56613633 |
| 93 | response to growth hormone (GO:0060416) | 2.56006609 |
| 94 | kidney morphogenesis (GO:0060993) | 2.55773773 |
| 95 | genitalia morphogenesis (GO:0035112) | 2.55147447 |
| 96 | interkinetic nuclear migration (GO:0022027) | 2.55069755 |
| 97 | regulation of cardioblast differentiation (GO:0051890) | 2.54052461 |
| 98 | keratinocyte proliferation (GO:0043616) | 2.53787369 |
| 99 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53213262 |
| 100 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.52578797 |
| 101 | lipoprotein metabolic process (GO:0042157) | 2.48781660 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.47688266 |
| 103 | bile acid and bile salt transport (GO:0015721) | 2.46815220 |
| 104 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.46800833 |
| 105 | negative regulation of glucose import (GO:0046325) | 2.45645173 |
| 106 | regulation of cholesterol esterification (GO:0010872) | 2.44902085 |
| 107 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.44679472 |
| 108 | cellular glucuronidation (GO:0052695) | 2.43931570 |
| 109 | embryonic axis specification (GO:0000578) | 2.43247627 |
| 110 | cysteine metabolic process (GO:0006534) | 2.42597658 |
| 111 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.42342590 |
| 112 | regulation of cholesterol homeostasis (GO:2000188) | 2.42036818 |
| 113 | regulation of hippo signaling (GO:0035330) | 2.40824055 |
| 114 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40386632 |
| 115 | sulfur amino acid catabolic process (GO:0000098) | 2.40297296 |
| 116 | activin receptor signaling pathway (GO:0032924) | 2.39965015 |
| 117 | regulation of male gonad development (GO:2000018) | 2.39439383 |
| 118 | positive regulation of male gonad development (GO:2000020) | 2.39047453 |
| 119 | negative regulation of protein localization to cell surface (GO:2000009) | 2.38406048 |
| 120 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.38256849 |
| 121 | lysine catabolic process (GO:0006554) | 2.38158553 |
| 122 | lysine metabolic process (GO:0006553) | 2.38158553 |
| 123 | prostate gland growth (GO:0060736) | 2.38085429 |
| 124 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.38041412 |
| 125 | arginine metabolic process (GO:0006525) | 2.37897996 |
| 126 | glutamate metabolic process (GO:0006536) | 2.37793501 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 2.34732925 |
| 128 | midgut development (GO:0007494) | 2.34563461 |
| 129 | atrial cardiac muscle cell action potential (GO:0086014) | 2.34152795 |
| 130 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.33524841 |
| 131 | cholesterol transport (GO:0030301) | 2.32589854 |
| 132 | sterol transport (GO:0015918) | 2.32589854 |
| 133 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.31880838 |
| 134 | negative regulation of hormone metabolic process (GO:0032351) | 2.31058718 |
| 135 | regulation of action potential (GO:0098900) | 2.30871131 |
| 136 | low-density lipoprotein particle remodeling (GO:0034374) | 2.30765604 |
| 137 | tachykinin receptor signaling pathway (GO:0007217) | 2.30477883 |
| 138 | alpha-amino acid catabolic process (GO:1901606) | 2.30183562 |
| 139 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.29594025 |
| 140 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.28802310 |
| 141 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.28681304 |
| 142 | uronic acid metabolic process (GO:0006063) | 2.28447442 |
| 143 | glucuronate metabolic process (GO:0019585) | 2.28447442 |
| 144 | response to BMP (GO:0071772) | 2.27647198 |
| 145 | cellular response to BMP stimulus (GO:0071773) | 2.27647198 |
| 146 | regulation of skeletal muscle contraction (GO:0014819) | 2.27615205 |
| 147 | positive regulation of hemostasis (GO:1900048) | 2.26195987 |
| 148 | positive regulation of blood coagulation (GO:0030194) | 2.26195987 |
| 149 | nucleobase catabolic process (GO:0046113) | 2.26143199 |
| 150 | replication fork processing (GO:0031297) | 2.25136343 |
| 151 | plasma lipoprotein particle organization (GO:0071827) | 2.24731257 |
| 152 | pancreas development (GO:0031016) | 2.24667731 |
| 153 | embryonic pattern specification (GO:0009880) | 2.24577893 |
| 154 | vascular smooth muscle contraction (GO:0014829) | 2.23866371 |
| 155 | renal tubule morphogenesis (GO:0061333) | 2.23789102 |
| 156 | regulation of triglyceride catabolic process (GO:0010896) | 2.23123717 |
| 157 | regulation of lipid catabolic process (GO:0050994) | 2.22451079 |
| 158 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.22283622 |
| 159 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.22197521 |
| 160 | nephron tubule formation (GO:0072079) | 2.21520767 |
| 161 | positive regulation of fatty acid oxidation (GO:0046321) | 2.21457907 |
| 162 | negative regulation of cellular carbohydrate metabolic process (GO:0010677) | 2.20735172 |
| 163 | regulation of glucokinase activity (GO:0033131) | 2.19603766 |
| 164 | regulation of hexokinase activity (GO:1903299) | 2.19603766 |
| 165 | drug catabolic process (GO:0042737) | 2.19496881 |
| 166 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.19378140 |
| 167 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.18861394 |
| 168 | nodal signaling pathway (GO:0038092) | 2.18671417 |
| 169 | benzene-containing compound metabolic process (GO:0042537) | 2.18542518 |
| 170 | cartilage morphogenesis (GO:0060536) | 2.18514663 |
| 171 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.18427151 |
| 172 | plasma membrane repair (GO:0001778) | 2.17656687 |
| 173 | cardiac muscle cell action potential (GO:0086001) | 2.16913660 |
| 174 | blood coagulation, intrinsic pathway (GO:0007597) | 2.16497938 |
| 175 | negative regulation of coagulation (GO:0050819) | 2.16268369 |
| 176 | phasic smooth muscle contraction (GO:0014821) | 2.15032426 |
| 177 | positive regulation of actin filament depolymerization (GO:0030836) | 2.14872093 |
| 178 | collagen fibril organization (GO:0030199) | 2.14369030 |
| 179 | intraciliary transport (GO:0042073) | 2.13967429 |
| 180 | platelet dense granule organization (GO:0060155) | 2.13669624 |
| 181 | regulation of axon guidance (GO:1902667) | 2.13590139 |
| 182 | somite rostral/caudal axis specification (GO:0032525) | 2.13457553 |
| 183 | regulation of protein autophosphorylation (GO:0031952) | 2.13226280 |
| 184 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.10261238 |
| 185 | positive regulation of muscle hypertrophy (GO:0014742) | 2.10261238 |
| 186 | regulation of calcium ion import (GO:0090279) | 2.09522797 |
| 187 | nucleus localization (GO:0051647) | 2.08011445 |
| 188 | embryonic heart tube development (GO:0035050) | 2.07412024 |
| 189 | nephron epithelium morphogenesis (GO:0072088) | 2.06414217 |
| 190 | nephron tubule morphogenesis (GO:0072078) | 2.06414217 |
| 191 | establishment of protein localization to Golgi (GO:0072600) | 2.03616886 |
| 192 | positive regulation of meiosis (GO:0045836) | 2.03358055 |
| 193 | myofibril assembly (GO:0030239) | 2.03227287 |
| 194 | photoreceptor cell maintenance (GO:0045494) | 2.03147763 |
| 195 | L-fucose catabolic process (GO:0042355) | 2.02940466 |
| 196 | fucose catabolic process (GO:0019317) | 2.02940466 |
| 197 | L-fucose metabolic process (GO:0042354) | 2.02940466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.79059888 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.99531280 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.78781553 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61092179 |
| 5 | FUS_26573619_Chip-Seq_HEK293_Human | 2.51562554 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43640953 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20175633 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.13385858 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.13331949 |
| 10 | EWS_26573619_Chip-Seq_HEK293_Human | 2.10962200 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10578749 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.09691997 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01426398 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98245692 |
| 15 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87414972 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86491819 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78227629 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74563902 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71449806 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70602977 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70446078 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70145287 |
| 23 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.68223028 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66595101 |
| 25 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64214434 |
| 26 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64214434 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63381611 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.63276046 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61725938 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60896714 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59526537 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59073734 |
| 33 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.58572668 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58279619 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55870524 |
| 36 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.55318779 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55198951 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54413291 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50813710 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50011133 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48973233 |
| 42 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48017820 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47748597 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.45783388 |
| 45 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45666545 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45511561 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43469709 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39316642 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38546877 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38263294 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38021625 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38021625 |
| 53 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37909924 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35846617 |
| 55 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35315314 |
| 56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34706951 |
| 57 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33953550 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.33745971 |
| 59 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.33546616 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33490467 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32725820 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.31456082 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29993737 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29993737 |
| 65 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29568248 |
| 66 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28370189 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28143857 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27821818 |
| 69 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27500666 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26742624 |
| 71 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.26150450 |
| 72 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25871446 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24988766 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24782151 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23334989 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23255460 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.21687150 |
| 78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20944217 |
| 79 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20699016 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18575176 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18538227 |
| 82 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16866903 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16215344 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15880315 |
| 85 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15604848 |
| 86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15154788 |
| 87 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14950819 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14537786 |
| 89 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14314297 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13641724 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13289448 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13103055 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12580950 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12451145 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.12257878 |
| 96 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11591953 |
| 97 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11587335 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11109272 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11058975 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10288789 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10288789 |
| 102 | TBL1_22424771_ChIP-Seq_293T_Human | 1.09884489 |
| 103 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09460569 |
| 104 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08796583 |
| 105 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08487788 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08261894 |
| 107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08198379 |
| 108 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07773543 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07766767 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06768929 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06233330 |
| 112 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06225797 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06108497 |
| 114 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.06066177 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05679996 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05326656 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04971951 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04496901 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03193806 |
| 120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02343545 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02158728 |
| 122 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.00841547 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00580724 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00571799 |
| 125 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99463648 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98941822 |
| 127 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98913617 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98741156 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98529576 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98009455 |
| 131 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97842553 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96817519 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95284771 |
| 134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94241835 |
| 135 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92681296 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92366081 |
| 137 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91159091 |
| 138 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.89336127 |
| 139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88975030 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88738711 |
| 141 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88337816 |
| 142 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88334979 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87083259 |
| 144 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85217322 |
| 145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83516439 |
| 146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81875245 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.81744341 |
| 148 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81734721 |
| 149 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81649226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.65901629 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.71891523 |
| 3 | MP0005083_abnormal_biliary_tract | 3.66281750 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.63131263 |
| 5 | MP0006054_spinal_hemorrhage | 3.62540096 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.56132980 |
| 7 | MP0005365_abnormal_bile_salt | 3.49814479 |
| 8 | MP0005360_urolithiasis | 3.23046122 |
| 9 | MP0003252_abnormal_bile_duct | 2.74346662 |
| 10 | MP0003195_calcinosis | 2.70338243 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.41792077 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26076870 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.17978436 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.17580992 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.09507732 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.07063116 |
| 17 | MP0000383_abnormal_hair_follicle | 2.04109896 |
| 18 | MP0005275_abnormal_skin_tensile | 1.96622804 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 1.96430885 |
| 20 | MP0004215_abnormal_myocardial_fiber | 1.94617849 |
| 21 | MP0010678_abnormal_skin_adnexa | 1.92144382 |
| 22 | MP0002938_white_spotting | 1.91203303 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.86412306 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.84039754 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.79959224 |
| 26 | MP0002102_abnormal_ear_morphology | 1.78742344 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.72671345 |
| 28 | MP0003890_abnormal_embryonic-extraembry | 1.71131909 |
| 29 | MP0005248_abnormal_Harderian_gland | 1.67329966 |
| 30 | MP0003868_abnormal_feces_composition | 1.65389566 |
| 31 | MP0009697_abnormal_copulation | 1.64229267 |
| 32 | MP0003937_abnormal_limbs/digits/tail_de | 1.61084759 |
| 33 | MP0002282_abnormal_trachea_morphology | 1.59046811 |
| 34 | MP0009250_abnormal_appendicular_skeleto | 1.58516518 |
| 35 | MP0000579_abnormal_nail_morphology | 1.57269690 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.57125467 |
| 37 | MP0002295_abnormal_pulmonary_circulatio | 1.56467324 |
| 38 | MP0000749_muscle_degeneration | 1.54944636 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.53119026 |
| 40 | MP0002254_reproductive_system_inflammat | 1.52408630 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.50623501 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.40503913 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.38166652 |
| 44 | MP0005171_absent_coat_pigmentation | 1.35999951 |
| 45 | MP0003755_abnormal_palate_morphology | 1.34318281 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.31842063 |
| 47 | MP0003283_abnormal_digestive_organ | 1.31410287 |
| 48 | MP0004484_altered_response_of | 1.28122942 |
| 49 | MP0003119_abnormal_digestive_system | 1.27799825 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.27407456 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.26918593 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.26789347 |
| 53 | MP0005620_abnormal_muscle_contractility | 1.26702043 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.25512226 |
| 55 | MP0005408_hypopigmentation | 1.24572650 |
| 56 | MP0003935_abnormal_craniofacial_develop | 1.20652006 |
| 57 | MP0000762_abnormal_tongue_morphology | 1.20325510 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.19166910 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.18438917 |
| 60 | MP0000647_abnormal_sebaceous_gland | 1.18244313 |
| 61 | MP0001661_extended_life_span | 1.17576479 |
| 62 | MP0004085_abnormal_heartbeat | 1.14954089 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.12346059 |
| 64 | MP0000538_abnormal_urinary_bladder | 1.12145969 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.11167721 |
| 66 | MP0001984_abnormal_olfaction | 1.10683335 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.10105460 |
| 68 | MP0000537_abnormal_urethra_morphology | 1.09744991 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.09526293 |
| 70 | MP0003279_aneurysm | 1.08699450 |
| 71 | MP0005332_abnormal_amino_acid | 1.07944829 |
| 72 | MP0002160_abnormal_reproductive_system | 1.07261774 |
| 73 | MP0004134_abnormal_chest_morphology | 1.07029865 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 1.05793252 |
| 75 | MP0001944_abnormal_pancreas_morphology | 1.04045685 |
| 76 | MP0002233_abnormal_nose_morphology | 1.03768806 |
| 77 | MP0000609_abnormal_liver_physiology | 1.03629925 |
| 78 | MP0009764_decreased_sensitivity_to | 1.03524312 |
| 79 | MP0002693_abnormal_pancreas_physiology | 1.01155834 |
| 80 | MP0005623_abnormal_meninges_morphology | 1.00009021 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.98946562 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.98668958 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.98495702 |
| 84 | MP0003045_fibrosis | 0.96886771 |
| 85 | MP0002972_abnormal_cardiac_muscle | 0.96254762 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.95340419 |
| 87 | MP0005187_abnormal_penis_morphology | 0.93240146 |
| 88 | MP0002109_abnormal_limb_morphology | 0.93226808 |
| 89 | MP0004272_abnormal_basement_membrane | 0.91542813 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.90308153 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.89869871 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.88929566 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.88323205 |
| 94 | MP0003385_abnormal_body_wall | 0.88212033 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.87660218 |
| 96 | MP0001286_abnormal_eye_development | 0.87571953 |
| 97 | MP0000427_abnormal_hair_cycle | 0.87523144 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.86697849 |
| 99 | MP0002009_preneoplasia | 0.86308422 |
| 100 | MP0004270_analgesia | 0.86085612 |
| 101 | MP0005253_abnormal_eye_physiology | 0.85728026 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.85655591 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.85027882 |
| 104 | MP0002060_abnormal_skin_morphology | 0.85002494 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.84720038 |
| 106 | MP0004885_abnormal_endolymph | 0.84673076 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.84523995 |
| 108 | MP0003122_maternal_imprinting | 0.84063479 |
| 109 | MP0009053_abnormal_anal_canal | 0.83188490 |
| 110 | MP0003942_abnormal_urinary_system | 0.83159679 |
| 111 | MP0004130_abnormal_muscle_cell | 0.82375073 |
| 112 | MP0002168_other_aberrant_phenotype | 0.81698909 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.81454788 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.81134232 |
| 115 | MP0004133_heterotaxia | 0.80172922 |
| 116 | MP0003646_muscle_fatigue | 0.79859727 |
| 117 | MP0002796_impaired_skin_barrier | 0.79201674 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.78847113 |
| 119 | MP0003941_abnormal_skin_development | 0.78737009 |
| 120 | MP0002115_abnormal_skeleton_extremities | 0.78693929 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.78481873 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.77078383 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.76787789 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.76009192 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.75255475 |
| 126 | MP0003943_abnormal_hepatobiliary_system | 0.75220185 |
| 127 | MP0002098_abnormal_vibrissa_morphology | 0.75120559 |
| 128 | MP0004043_abnormal_pH_regulation | 0.73106418 |
| 129 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72610406 |
| 130 | MP0000516_abnormal_urinary_system | 0.72481272 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.72481272 |
| 132 | MP0000432_abnormal_head_morphology | 0.72214777 |
| 133 | MP0001486_abnormal_startle_reflex | 0.71517421 |
| 134 | MP0005334_abnormal_fat_pad | 0.70633174 |
| 135 | MP0009840_abnormal_foam_cell | 0.69471667 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.69382815 |
| 137 | MP0001270_distended_abdomen | 0.69377597 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.69246087 |
| 139 | MP0002127_abnormal_cardiovascular_syste | 0.68929224 |
| 140 | MP0001756_abnormal_urination | 0.68797976 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.68783238 |
| 142 | MP0000631_abnormal_neuroendocrine_gland | 0.68058064 |
| 143 | MP0005257_abnormal_intraocular_pressure | 0.67950114 |
| 144 | MP0002128_abnormal_blood_circulation | 0.67805717 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.67537409 |
| 146 | MP0005535_abnormal_body_temperature | 0.67230966 |
| 147 | MP0003959_abnormal_lean_body | 0.67073757 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.64790435 |
| 149 | MP0001881_abnormal_mammary_gland | 0.64493445 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.62896157 |
| 151 | MP0002234_abnormal_pharynx_morphology | 0.62277317 |
| 152 | MP0003303_peritoneal_inflammation | 0.61745926 |
| 153 | MP0004859_abnormal_synaptic_plasticity | 0.61343718 |
| 154 | MP0002177_abnormal_outer_ear | 0.61181086 |
| 155 | MP0005508_abnormal_skeleton_morphology | 0.61046599 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.60925931 |
| 157 | MP0003091_abnormal_cell_migration | 0.60885314 |
| 158 | MP0002928_abnormal_bile_duct | 0.60310200 |
| 159 | MP0005448_abnormal_energy_balance | 0.60215416 |
| 160 | MP0001177_atelectasis | 0.58910044 |
| 161 | MP0001191_abnormal_skin_condition | 0.58782494 |
| 162 | MP0000371_diluted_coat_color | 0.57395005 |
| 163 | MP0005647_abnormal_sex_gland | 0.56670859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 4.51799811 |
| 2 | Joint hemorrhage (HP:0005261) | 4.50385402 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.23661404 |
| 4 | Epidermoid cyst (HP:0200040) | 4.21005729 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.19806270 |
| 6 | Xanthomatosis (HP:0000991) | 4.04247097 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.01092360 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.53992941 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49872643 |
| 10 | Ketoacidosis (HP:0001993) | 3.44930613 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 3.43638692 |
| 12 | Skin nodule (HP:0200036) | 3.36743216 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.27886974 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.24941231 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.03950368 |
| 16 | Complement deficiency (HP:0004431) | 3.01918734 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 2.96738809 |
| 18 | Mucopolysacchariduria (HP:0008155) | 2.93723505 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.93723505 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 2.93197136 |
| 21 | Symptomatic seizures (HP:0011145) | 2.81866129 |
| 22 | Myocardial infarction (HP:0001658) | 2.81736773 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 2.79637680 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.77159064 |
| 25 | J-shaped sella turcica (HP:0002680) | 2.76835091 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75919139 |
| 27 | Abnormality of the ischium (HP:0003174) | 2.73895209 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72235125 |
| 29 | Menorrhagia (HP:0000132) | 2.68364998 |
| 30 | Hypolipoproteinemia (HP:0010981) | 2.67748324 |
| 31 | Turricephaly (HP:0000262) | 2.66646127 |
| 32 | Ketosis (HP:0001946) | 2.64186598 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 2.62948289 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61674179 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61674179 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61674179 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.59036339 |
| 38 | Renal cortical cysts (HP:0000803) | 2.57188531 |
| 39 | Hyperglycemia (HP:0003074) | 2.56884137 |
| 40 | Hypoplastic labia majora (HP:0000059) | 2.55406793 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52062730 |
| 42 | Abnormality of complement system (HP:0005339) | 2.47683319 |
| 43 | Abnormality of the labia majora (HP:0012881) | 2.46681528 |
| 44 | Hypoplastic ischia (HP:0003175) | 2.44606992 |
| 45 | Tubular atrophy (HP:0000092) | 2.41948990 |
| 46 | Disproportionate short-trunk short stature (HP:0003521) | 2.41131665 |
| 47 | Amniotic constriction ring (HP:0009775) | 2.40904125 |
| 48 | Abnormality of placental membranes (HP:0011409) | 2.40904125 |
| 49 | Increased corneal curvature (HP:0100692) | 2.40680027 |
| 50 | Keratoconus (HP:0000563) | 2.40680027 |
| 51 | Abnormality of the lumbar spine (HP:0100712) | 2.39793642 |
| 52 | Intestinal atresia (HP:0011100) | 2.38926208 |
| 53 | Abnormality of the neuromuscular junction (HP:0003398) | 2.34275957 |
| 54 | Fatigable weakness (HP:0003473) | 2.34275957 |
| 55 | Generalized hypopigmentation of hair (HP:0011358) | 2.34019372 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.31309613 |
| 57 | Pancreatic cysts (HP:0001737) | 2.31034766 |
| 58 | Fair hair (HP:0002286) | 2.31004175 |
| 59 | Fat malabsorption (HP:0002630) | 2.30332545 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.29718509 |
| 61 | Molar tooth sign on MRI (HP:0002419) | 2.29718509 |
| 62 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.28814935 |
| 63 | True hermaphroditism (HP:0010459) | 2.28575812 |
| 64 | Alopecia of scalp (HP:0002293) | 2.27949094 |
| 65 | Onycholysis (HP:0001806) | 2.27499190 |
| 66 | Mitral stenosis (HP:0001718) | 2.26543604 |
| 67 | Enlarged penis (HP:0000040) | 2.20605473 |
| 68 | Aortic dissection (HP:0002647) | 2.20509345 |
| 69 | Volvulus (HP:0002580) | 2.20349842 |
| 70 | Abnormal pancreas size (HP:0012094) | 2.19638032 |
| 71 | Blue irides (HP:0000635) | 2.19476461 |
| 72 | Atrophic scars (HP:0001075) | 2.16758544 |
| 73 | Metatarsus adductus (HP:0001840) | 2.15461506 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15258270 |
| 75 | Short hallux (HP:0010109) | 2.14477168 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.11474917 |
| 77 | Nephronophthisis (HP:0000090) | 2.10346151 |
| 78 | Popliteal pterygium (HP:0009756) | 2.09845956 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.09589346 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.04869416 |
| 81 | Limited hip movement (HP:0008800) | 2.04272601 |
| 82 | Lymphangioma (HP:0100764) | 2.02670656 |
| 83 | Furrowed tongue (HP:0000221) | 2.02335200 |
| 84 | Albinism (HP:0001022) | 2.02144636 |
| 85 | Abnormality of the calf musculature (HP:0001430) | 1.98586867 |
| 86 | Eczematoid dermatitis (HP:0000976) | 1.97413550 |
| 87 | Asymmetry of the thorax (HP:0001555) | 1.97205803 |
| 88 | Abnormality of the nasal septum (HP:0000419) | 1.96463425 |
| 89 | Follicular hyperkeratosis (HP:0007502) | 1.96052652 |
| 90 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.95497594 |
| 91 | Plantar hyperkeratosis (HP:0007556) | 1.95252259 |
| 92 | Recurrent corneal erosions (HP:0000495) | 1.94457400 |
| 93 | Aortic aneurysm (HP:0004942) | 1.94399756 |
| 94 | Chorioretinal atrophy (HP:0000533) | 1.93466383 |
| 95 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93378665 |
| 96 | Hematochezia (HP:0002573) | 1.91212553 |
| 97 | Hyperventilation (HP:0002883) | 1.90883473 |
| 98 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.90795560 |
| 99 | Preaxial foot polydactyly (HP:0001841) | 1.90272556 |
| 100 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.89731358 |
| 101 | Hypercholesterolemia (HP:0003124) | 1.88979948 |
| 102 | Abnormality of the axillary hair (HP:0100134) | 1.88782197 |
| 103 | Abnormality of secondary sexual hair (HP:0009888) | 1.88782197 |
| 104 | Palmar hyperkeratosis (HP:0010765) | 1.88468036 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.88163266 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 1.88163266 |
| 107 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.87998827 |
| 108 | Aqueductal stenosis (HP:0002410) | 1.87645333 |
| 109 | Bifid tongue (HP:0010297) | 1.86908180 |
| 110 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.84861293 |
| 111 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84068341 |
| 112 | Late onset (HP:0003584) | 1.83930572 |
| 113 | Abnormality of methionine metabolism (HP:0010901) | 1.83817874 |
| 114 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.82896730 |
| 115 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82705267 |
| 116 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82628233 |
| 117 | Palmoplantar hyperkeratosis (HP:0000972) | 1.82623212 |
| 118 | Gastrointestinal atresia (HP:0002589) | 1.81376746 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 1.80743787 |
| 120 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80271118 |
| 121 | Hypoplastic iliac wings (HP:0002866) | 1.79528291 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.78637813 |
| 123 | Genital tract atresia (HP:0001827) | 1.78060013 |
| 124 | Cystic hygroma (HP:0000476) | 1.77000108 |
| 125 | Hepatoblastoma (HP:0002884) | 1.76753067 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.75562589 |
| 127 | Large for gestational age (HP:0001520) | 1.75037015 |
| 128 | Aplasia of the musculature (HP:0100854) | 1.74724254 |
| 129 | Spontaneous abortion (HP:0005268) | 1.74449890 |
| 130 | Febrile seizures (HP:0002373) | 1.73618404 |
| 131 | Labial hypoplasia (HP:0000066) | 1.72516111 |
| 132 | Hyporeflexia of lower limbs (HP:0002600) | 1.72415717 |
| 133 | Delayed gross motor development (HP:0002194) | 1.72404953 |
| 134 | Curly hair (HP:0002212) | 1.72341996 |
| 135 | Hypothermia (HP:0002045) | 1.71527538 |
| 136 | Agitation (HP:0000713) | 1.71485940 |
| 137 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.71383939 |
| 138 | Beaking of vertebral bodies (HP:0004568) | 1.70987686 |
| 139 | Vaginal atresia (HP:0000148) | 1.70469339 |
| 140 | Generalized hypopigmentation (HP:0007513) | 1.70265623 |
| 141 | Type 1 muscle fiber predominance (HP:0003803) | 1.70122103 |
| 142 | Exotropia (HP:0000577) | 1.69459315 |
| 143 | Atrial fibrillation (HP:0005110) | 1.68648019 |
| 144 | Generalized tonic-clonic seizures (HP:0002069) | 1.68544778 |
| 145 | Hamartoma of the eye (HP:0010568) | 1.68191353 |
| 146 | Vascular calcification (HP:0004934) | 1.68020630 |
| 147 | Fetal akinesia sequence (HP:0001989) | 1.66892796 |
| 148 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.65582696 |
| 149 | Gastrointestinal infarctions (HP:0005244) | 1.65371738 |
| 150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.64502548 |
| 151 | Abnormality of alanine metabolism (HP:0010916) | 1.64502548 |
| 152 | Hyperalaninemia (HP:0003348) | 1.64502548 |
| 153 | Exostoses (HP:0100777) | 1.64376650 |
| 154 | Soft skin (HP:0000977) | 1.64376349 |
| 155 | Hip contracture (HP:0003273) | 1.63824717 |
| 156 | Akinesia (HP:0002304) | 1.63509150 |
| 157 | Widely spaced teeth (HP:0000687) | 1.61315619 |
| 158 | Distal arthrogryposis (HP:0005684) | 1.61164875 |
| 159 | Gingival bleeding (HP:0000225) | 1.60903851 |
| 160 | Alveolar cell carcinoma (HP:0006519) | 1.60474345 |
| 161 | Hyperammonemia (HP:0001987) | 1.59995977 |
| 162 | Sensorimotor neuropathy (HP:0007141) | 1.59875437 |
| 163 | Macroorchidism (HP:0000053) | 1.59634049 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.59312212 |
| 165 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.58992039 |
| 166 | Small hand (HP:0200055) | 1.58343208 |
| 167 | Decreased lacrimation (HP:0000633) | 1.58124919 |
| 168 | Mesomelia (HP:0003027) | 1.57981060 |
| 169 | Abnormality of purine metabolism (HP:0004352) | 1.57730670 |
| 170 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.57365123 |
| 171 | Gaze-evoked nystagmus (HP:0000640) | 1.57313023 |
| 172 | Broad metatarsal (HP:0001783) | 1.57172182 |
| 173 | Malignant hyperthermia (HP:0002047) | 1.57089006 |
| 174 | Systemic lupus erythematosus (HP:0002725) | 1.57025836 |
| 175 | Hypophosphatemic rickets (HP:0004912) | 1.55686096 |
| 176 | Preauricular pit (HP:0004467) | 1.55262188 |
| 177 | Periauricular skin pits (HP:0100277) | 1.55262188 |
| 178 | Syringomyelia (HP:0003396) | 1.53640524 |
| 179 | Spinal cord lesions (HP:0100561) | 1.53640524 |
| 180 | Duplicated collecting system (HP:0000081) | 1.53513071 |
| 181 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.53509340 |
| 182 | Decreased muscle mass (HP:0003199) | 1.52852843 |
| 183 | Conjunctival hamartoma (HP:0100780) | 1.52683865 |
| 184 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.52532901 |
| 185 | Thoracic kyphosis (HP:0002942) | 1.52231182 |
| 186 | Abnormality of the renal collecting system (HP:0004742) | 1.51841155 |
| 187 | Hypoplasia of the uterus (HP:0000013) | 1.51579076 |
| 188 | Thin bony cortex (HP:0002753) | 1.51481630 |
| 189 | Absent phalangeal crease (HP:0006109) | 1.51154722 |
| 190 | Gingivitis (HP:0000230) | 1.48608546 |
| 191 | Widely patent fontanelles and sutures (HP:0004492) | 1.47841648 |
| 192 | Hypophosphatemia (HP:0002148) | 1.46745353 |
| 193 | Esophageal varix (HP:0002040) | 1.46253295 |
| 194 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.45811102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.43713756 |
| 2 | EPHA3 | 3.37866517 |
| 3 | INSRR | 3.29593367 |
| 4 | ACVR1B | 2.77566250 |
| 5 | WNK3 | 2.68464092 |
| 6 | MAP3K4 | 2.53521315 |
| 7 | MKNK2 | 2.37013337 |
| 8 | NTRK3 | 2.34963160 |
| 9 | TNIK | 2.34702954 |
| 10 | MAP3K2 | 2.32194384 |
| 11 | FER | 2.22405836 |
| 12 | TRIM28 | 2.12043371 |
| 13 | MAP2K4 | 2.09575626 |
| 14 | MAP2K7 | 1.99826587 |
| 15 | STK38L | 1.99096299 |
| 16 | LATS1 | 1.96546752 |
| 17 | MST1R | 1.96351369 |
| 18 | EPHB2 | 1.95216243 |
| 19 | FGFR4 | 1.89481216 |
| 20 | DDR2 | 1.76752632 |
| 21 | PNCK | 1.74366659 |
| 22 | GRK1 | 1.73060631 |
| 23 | FLT3 | 1.68950366 |
| 24 | ERBB4 | 1.68158041 |
| 25 | PTK6 | 1.63402464 |
| 26 | MST4 | 1.58884185 |
| 27 | FGFR3 | 1.58859345 |
| 28 | MARK1 | 1.58700787 |
| 29 | BRSK2 | 1.54822900 |
| 30 | MKNK1 | 1.54265365 |
| 31 | STK39 | 1.53912824 |
| 32 | ADRBK2 | 1.42560377 |
| 33 | MAP4K2 | 1.42227361 |
| 34 | MYLK | 1.42022425 |
| 35 | ERBB3 | 1.40279650 |
| 36 | SIK1 | 1.37702296 |
| 37 | PDK2 | 1.37320376 |
| 38 | BMPR1B | 1.37227344 |
| 39 | TRIB3 | 1.31394140 |
| 40 | MAP3K14 | 1.28825449 |
| 41 | TGFBR2 | 1.28412177 |
| 42 | PRKD3 | 1.26699049 |
| 43 | KSR2 | 1.24758630 |
| 44 | TIE1 | 1.21509629 |
| 45 | DAPK2 | 1.18193994 |
| 46 | PAK3 | 1.15931825 |
| 47 | OXSR1 | 1.15513862 |
| 48 | PINK1 | 1.15404299 |
| 49 | PIK3CG | 1.14626235 |
| 50 | FGFR2 | 1.12451381 |
| 51 | RET | 1.11616584 |
| 52 | WEE1 | 1.10113777 |
| 53 | STK3 | 1.08688818 |
| 54 | EIF2AK3 | 1.07755667 |
| 55 | IRAK3 | 1.07587763 |
| 56 | NEK9 | 1.06316930 |
| 57 | CAMKK1 | 1.05733890 |
| 58 | MAP3K1 | 1.05440141 |
| 59 | MAP3K3 | 1.03898039 |
| 60 | NTRK1 | 1.02618571 |
| 61 | ZAK | 1.01659702 |
| 62 | JAK1 | 1.00793772 |
| 63 | PDGFRA | 0.99600871 |
| 64 | NLK | 0.99191725 |
| 65 | CAMKK2 | 0.98985669 |
| 66 | ABL2 | 0.96559357 |
| 67 | PLK4 | 0.94526125 |
| 68 | IRAK1 | 0.94281905 |
| 69 | MET | 0.94234080 |
| 70 | AKT3 | 0.93865190 |
| 71 | EPHB1 | 0.91766654 |
| 72 | ADRBK1 | 0.91287233 |
| 73 | PAK6 | 0.91093743 |
| 74 | TAOK3 | 0.90485455 |
| 75 | PRKCE | 0.88846397 |
| 76 | SGK2 | 0.85990572 |
| 77 | JAK2 | 0.85332630 |
| 78 | RIPK1 | 0.84048868 |
| 79 | BMX | 0.83674559 |
| 80 | MAP2K1 | 0.81567062 |
| 81 | ROCK1 | 0.81054940 |
| 82 | OBSCN | 0.80943438 |
| 83 | ERN1 | 0.80914432 |
| 84 | BCR | 0.80835611 |
| 85 | PRKCH | 0.78801682 |
| 86 | SGK3 | 0.77616382 |
| 87 | PLK3 | 0.77592759 |
| 88 | MAP3K12 | 0.76285731 |
| 89 | PTK2 | 0.74889697 |
| 90 | MAPKAPK3 | 0.73869339 |
| 91 | MAPKAPK5 | 0.72137159 |
| 92 | TTN | 0.69871953 |
| 93 | MAP3K9 | 0.68293031 |
| 94 | FGFR1 | 0.65629966 |
| 95 | NUAK1 | 0.63154811 |
| 96 | CSNK1G1 | 0.63074989 |
| 97 | GRK7 | 0.61845597 |
| 98 | TGFBR1 | 0.59558971 |
| 99 | KSR1 | 0.59412396 |
| 100 | MINK1 | 0.58938297 |
| 101 | GSK3A | 0.58885348 |
| 102 | HIPK2 | 0.58779166 |
| 103 | WNK4 | 0.58479055 |
| 104 | LATS2 | 0.57644590 |
| 105 | STK24 | 0.56976212 |
| 106 | PKN2 | 0.56926744 |
| 107 | CASK | 0.56753401 |
| 108 | PHKG1 | 0.56616440 |
| 109 | PHKG2 | 0.56616440 |
| 110 | PTK2B | 0.55789373 |
| 111 | PRKAA1 | 0.53871693 |
| 112 | NEK1 | 0.53700607 |
| 113 | MELK | 0.53150200 |
| 114 | NTRK2 | 0.52686674 |
| 115 | CDK5 | 0.50578220 |
| 116 | DYRK1B | 0.50124860 |
| 117 | CAMK2A | 0.50084423 |
| 118 | PRKACG | 0.49515563 |
| 119 | MUSK | 0.49181126 |
| 120 | PRKAA2 | 0.48869266 |
| 121 | PRKCZ | 0.48866710 |
| 122 | DMPK | 0.48079087 |
| 123 | PBK | 0.47748975 |
| 124 | SGK1 | 0.46877199 |
| 125 | LIMK1 | 0.46332380 |
| 126 | PIK3CA | 0.45429039 |
| 127 | PRKCG | 0.45396457 |
| 128 | PLK2 | 0.45393153 |
| 129 | CSNK1G2 | 0.44848159 |
| 130 | PAK2 | 0.43958076 |
| 131 | TRPM7 | 0.43760884 |
| 132 | RPS6KB1 | 0.43594183 |
| 133 | MAPK13 | 0.43118367 |
| 134 | CAMK1G | 0.43106822 |
| 135 | MOS | 0.42639544 |
| 136 | PDGFRB | 0.41866622 |
| 137 | IGF1R | 0.40332024 |
| 138 | CDK9 | 0.40284428 |
| 139 | CDK6 | 0.39942189 |
| 140 | RPS6KA2 | 0.39547967 |
| 141 | TNK2 | 0.39477351 |
| 142 | CAMK1D | 0.39056598 |
| 143 | EPHA4 | 0.38328640 |
| 144 | ERBB2 | 0.38313734 |
| 145 | SGK223 | 0.37675535 |
| 146 | SGK494 | 0.37675535 |
| 147 | CAMK2D | 0.36862413 |
| 148 | CSNK1A1L | 0.35630363 |
| 149 | BMPR2 | 0.35606401 |
| 150 | STK10 | 0.34774045 |
| 151 | STK16 | 0.33144268 |
| 152 | TEC | 0.32706856 |
| 153 | ABL1 | 0.31624661 |
| 154 | PRKG1 | 0.30028826 |
| 155 | ATM | 0.28128422 |
| 156 | TLK1 | 0.27027372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.16792214 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74477707 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.38404869 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35364945 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32936422 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.25655215 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.20935727 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.18771376 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12713028 |
| 10 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.93767070 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90549950 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87109216 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.86738360 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.75983960 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73333080 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.72738939 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67310145 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64721741 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.63320456 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62585543 |
| 21 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.62531099 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.59532823 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52956547 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49780404 |
| 25 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.42202569 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41170382 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40711927 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39120703 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38482088 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37284885 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.36340103 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36175716 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32900559 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.32099718 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31353073 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30454998 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30326628 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.29978778 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.24066535 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23128553 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21063985 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20764731 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19661545 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18573866 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17785678 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13686582 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.11986729 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.09656958 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09119709 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.08456612 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07397906 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05029425 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04635962 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02911422 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 1.01360909 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96904045 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.96193673 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95437844 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91486895 |
| 60 | Melanoma_Homo sapiens_hsa05218 | 0.90488022 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.85820360 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85690314 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85148145 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.84139263 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81260664 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.80390137 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.79819398 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78631817 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78354880 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77489921 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77143974 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.75839286 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73995611 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73327105 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71202353 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.70172309 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69463098 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68931074 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68696190 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66361751 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65896366 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65489975 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65117371 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65110413 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64925284 |
| 86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64174197 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63841236 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62567931 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62454267 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61679330 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.61322687 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.60914837 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60845694 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60513531 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58245648 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58199537 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57976627 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56707977 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56267690 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55853630 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55332916 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55113384 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53699288 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53332255 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.52720644 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52471396 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52436814 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52242740 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52067318 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51896374 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51879762 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.50937131 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50866493 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49279045 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49063988 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.48718948 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.48605137 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48232023 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.48127512 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47831879 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47136128 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47002098 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.44943305 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44842473 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44322433 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.43661643 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.43441226 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43321862 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43131801 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43112857 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42935243 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42886239 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42569475 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42471012 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42389633 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.40890657 |
| 137 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40216693 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39973658 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39467273 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39419148 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39398144 |
| 142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39264358 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38707581 |
| 144 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38689183 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38163579 |
| 146 | Focal adhesion_Homo sapiens_hsa04510 | 0.37863483 |
| 147 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37582988 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37435394 |
| 149 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37179938 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36863644 |
| 151 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36460003 |

